RankingsPricing
  1. US-listed companies
  2. GLOBUS MEDICAL INC
  3. Financials
  4. Research & development

GLOBUS MEDICAL INCGMED

Market cap
$11.6B
P/E ratio
SummaryFinancials
Period EndResearch & development (Million USD)YoY (%)
Dec 31, 2024164+32.05%
Dec 31, 2023124+69.84%
Dec 31, 202273-24.99%
Dec 31, 202197+15.18%
Dec 31, 202085+40.69%
Dec 31, 201960+8.25%
Dec 31, 201855+27.05%
Dec 31, 201744-1.92%
Dec 31, 201645+20.42%
Dec 31, 201537+16.71%
Dec 31, 201432+17.93%
Dec 31, 201327-3.78%
Dec 31, 201228

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)